v3.26.1
Summary of Significant Accounting Policies - Schedule of Assets and Liabilities Measured at Fair Value (Details) - USD ($)
 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Schedule of Assets and Liabilities Measured at Fair Value [Line Items]    
Beginning balance $ 84,591 $ 288,833
Change in fair value of derivative liabilities $ (202,959) (204,242)
Exercise (in Shares) (4,099)  
Derivative Liabilities Recognized at Grant Date $ 5,737,755  
Ending balance 5,615,288 84,591
Recurring [Member]    
Schedule of Assets and Liabilities Measured at Fair Value [Line Items]    
Beginning balance 84,591  
Ending balance 5,615,288 84,591
Recurring [Member] | August 2020 [Member] | Underwritten Public Offering Warrants [Member]    
Schedule of Assets and Liabilities Measured at Fair Value [Line Items]    
Beginning balance 21 3,219
Change in fair value of derivative liabilities $ (21) (3,198)
Exercise (in Shares)  
Ending balance 21
Recurring [Member] | February 2021 [Member] | Registered Direct Offering Warrants [Member]    
Schedule of Assets and Liabilities Measured at Fair Value [Line Items]    
Beginning balance 219 4,333
Change in fair value of derivative liabilities $ (219) (4,114)
Exercise (in Shares)  
Ending balance 219
Recurring [Member] | May 2021 [Member] | Registered Direct Offering Placement Warrants [Member]    
Schedule of Assets and Liabilities Measured at Fair Value [Line Items]    
Beginning balance 962 6,048
Change in fair value of derivative liabilities $ (962) (5,086)
Exercise (in Shares)  
Ending balance 962
Recurring [Member] | May 2021 [Member] | Registered Direct Offering Investors Warrants [Member]    
Schedule of Assets and Liabilities Measured at Fair Value [Line Items]    
Beginning balance 12,823 80,636
Change in fair value of derivative liabilities $ (12,823) (67,813)
Exercise (in Shares)  
Ending balance 12,823
Recurring [Member] | November 2021 [Member] | Private Placement Placement Warrants [Member]    
Schedule of Assets and Liabilities Measured at Fair Value [Line Items]    
Beginning balance 5,980 15,077
Change in fair value of derivative liabilities $ (5,980) (9,097)
Exercise (in Shares)  
Ending balance 5,980
Recurring [Member] | November 2021 [Member] | Private Placement Offering Warrants [Member]    
Schedule of Assets and Liabilities Measured at Fair Value [Line Items]    
Beginning balance 64,586 179,520
Change in fair value of derivative liabilities $ (60,487) (114,934)
Exercise (in Shares) (4,099)  
Ending balance 64,586
Recurring [Member] | November 2025 [Member] | Registered Direct Offering Warrants [Member]    
Schedule of Assets and Liabilities Measured at Fair Value [Line Items]    
Beginning balance
Change in fair value of derivative liabilities $ 108,599
Exercise (in Shares)  
Derivative Liabilities Recognized at Grant Date $ 1,013,590  
Ending balance 1,122,189
Recurring [Member] | November 2025 [Member] | Private Placement Investors Warrants [Member]    
Schedule of Assets and Liabilities Measured at Fair Value [Line Items]    
Beginning balance
Change in fair value of derivative liabilities $ (231,066)
Exercise (in Shares)  
Derivative Liabilities Recognized at Grant Date $ 4,724,165  
Ending balance $ 4,493,099